616 results on '"Fung, Henry"'
Search Results
52. Impacts of the socio-political instability in Hong Kong on university students’ learning experience
53. Impact of Psychological Distress on Immune Phenotype in CLL/SLL Patients Managed By Active Observation
54. A Single Center Retrospective Analysis Comparing the Outcomes of Induction Therapy between 7+3 and FLAG-IDA/Venetoclax in Newly Diagnosed Patients with Acute Myeloid Leukemia
55. Molecular Monitoring with Tumor DNA and Nivolumab Maintenance: A Pilot Study in Diffuse Large B-Cell Lymphoma
56. One-Year Follow-up of ZUMA-2, the Multicenter, Registrational Study of KTE-X19 in Patients with Relapsed/Refractory Mantle Cell Lymphoma
57. Outcomes in ZUMA-5 with axicabtagene ciloleucel (axi-cel) in patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) who had the high-risk feature of progression within 24 months from initiation of first anti-CD20–containing chemoimmunotherapy (POD24).
58. Retrospective Analysis of Efficacy and Toxicity of Melphalan 200mg/m2 and 140mg/m2 for Autologous Stem Cell Transplant in Multiple Myeloma
59. Primary Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
60. One-Year Follow-up of ZUMA-2, the Multicenter, Registrational Study of KTE-X19 in Patients (Pts) with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL)
61. Effects of Post-Transplant Cyclophosphamide on Early Donor Chimerism Outcomes after Allogeneic Stem Cell Transplant with Busulfan Based Myeloablative Conditioning
62. The role of dopamine dysregulation and evidence for the transdiagnostic nature of elevated dopamine synthesis in psychosis: a positron emission tomography (PET) study comparing schizophrenia, delusional disorder, and other psychotic disorders
63. The role of dopamine dysregulation and evidence for the transdiagnostic nature of elevated dopamine synthesis in psychosis
64. Tandem Autologous Stem Cell Transplantation for Patients with Primary Refractory or Poor Risk Recurrent Hodgkin Lymphoma
65. Utility of high-throughput sequencing of T-cell receptor rearrangements in assessing treatment response in patients with mature T-cell lymphoma
66. Loss of CD26 protease activity in recipient mice during hematopoietic stem cell transplantation results in improved transplant efficiency
67. Does Follicularity in Large Cell Lymphoma Predict Outcome after Autologous Stem Cell Transplantation?
68. 418 - Day 30 and Day 100 CD3 Chimerism Levels Are Not Predictive of Progression Free Survival, Overall Survival and Gvhd Outcomes in Allogenic Stem Cell Transplants Using Post-Transplant Cyclophosphamide
69. 342 - Safety and Efficacy of Gvhd Prophylaxis with Abatacept and Reduced Dose Post-Transplant Cytoxan in Matched Unrelated and Matched Related Allogeneic Peripheral Stem Cell Transplants
70. 142 - Safety and Efficacy of Oral Vancomycin Prophylaxis Against Clostridioides Difficile Infection in Stem Cell Transplant Recipients
71. 87 - Importance of Monitoring Stem Cell Apheresis Efficiency
72. Cellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics
73. Primary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
74. A Phase I Trial Assessing the Feasibility of Romidepsin Combined with Brentuximab Vedotin for Patients Requiring Systemic Therapy for Cutaneous T-Cell Lymphoma
75. IBCL-124: Interim Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (R/R iNHL)
76. Interim analysis of ZUMA-5: A phase II study of axicabtagene ciloleucel (axi-cel) in patients (pts) with relapsed/refractory indolent non-Hodgkin lymphoma (R/R iNHL).
77. KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
78. The Impact of Peripheral Stem Cell As a Stem Cell Source on Gvhd for Patients Receiving Post-Transplant High Dose Cyclophosphamide As Gvhd Prophylaxis after an Allogeneic Transplant
79. Stem cell transplantation
80. A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma
81. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease
82. Mesenchymal stem cells from the Whartonʼs jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture
83. Mammary Analogue Secretory Carcinoma of the Palate: Case Report and Review of the Literature
84. Reconstruction for Complex Oromandibular Facial Defects: The Fibula Free Flap and Pectoralis Major Flap Combination
85. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease
86. Longitudinal Assessment of Hematopoietic Abnormalities After Autologous Hematopoietic Cell Transplantation for Lymphoma
87. Interleukin-2 After Autologous Stem-Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete Remission
88. Is There an Association Between Total-Body Irradiation and Secondary Acute Myelogenous Leukemia/Myelodysplastic Syndrome in Patients With Relapsed/Refractory Hodgkin’s Disease Treated With Autologous Stem-Cell Transplantation?
89. Solid Cancers After Bone Marrow Transplantation
90. 606 - Uniform Plerixafor Dosing for Patients Greater Than 83 Kg
91. 594 - Fox Chase-Temple University Hospital BMT Program Experience of New Database Development
92. 329 - Efficacy of Post-Transplant Cytoxan for Gvhd Prophylaxis in Mismatched Unrelated Allogeneic Stem Cell Transplant
93. Autologous Stem-Cell Transplantation for Poor-Risk and Relapsed Intermediate- and High-Grade Non-Hodgkinʼs Lymphoma
94. Super Slice Interpolation For Generating Thin-Slice Images From Multichannel Multislice MRI Data
95. Pembrolizumab and Copanlisib for the Treatment of Relapsed or Refractory Mature T-Cell Lymphomas
96. Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
97. Engineering of Chimeric Antigen Receptor T Cells with integrin αEβ7 Results in Augmented Therapeutic Efficacy against E-cadherin positive tumor
98. Bloodless Autologous Hematopoeitic Stem Cell Transplant: An Alternative for Jehovah's Witnesses and Others Who Prefer to Go Bloodless
99. Impact of Post-Transplant High-Dose Cyclophosphamide and Donor Sources on CMV Reactivation.
100. Integrate PCMCIA sockets into desktops
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.